Evidence map›Paper›PMID 32796580›Full record

ArticlePlants (Basel, Switzerland)2020

A New Active Substance Derived from Lyzed

Sandrine Demanèche, Laurène Mirabel, Olivier Abbe, Jean-Baptiste Eberst, Jean-Luc Souche

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Broad-Spectrum Efficacy and Modes of Action of TwoJournal of fungi (Basel, Switzerland) · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sandrine DemanècheR&D Department, Amoéba, 69680 Chassieu, France.ORCID 0000-0002-7430-9209
Laurène MirabelR&D Department, Amoéba, 69680 Chassieu, France.
Olivier AbbeR&D Department, Amoéba, 69680 Chassieu, France.
Jean-Baptiste EberstR&D Department, Amoéba, 69680 Chassieu, France.
Jean-Luc SoucheR&D Department, Amoéba, 69680 Chassieu, France.
Amer Sports (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Downy mildew of grapevine is one of the most destructive grapevine diseases worldwide. Nowadays, downy mildew control relies almost exclusively on the use of chemical pesticides, including copper products, which are efficient but controversial due to their environmental toxicity. Natural plant protection products have become important solutions in the quest for the sustainable production of food and pest management. However, most biocontrol agents currently on the market, such as biofungicides or elicitors, have a limited efficacy; thus, they cannot replace chemical compounds in full. Our innovation is a natural active substance, which is a lysate of the amoeba

Indexed as

biofungicidedowny mildewgrapevinePlasmopara viticolaWillaertia magna C2c Maky

Identifiers

PMID32796580
PMCPMC7463879
OpenAlexW3048924487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.